Carboplatine Viatris 10 mg/mL (450 mg/45 mL) Injection in Pakistan

Carboplatine Viatris 450 mg/45 mL is an oncology medicine containing carboplatin, a platinum-based chemotherapy agent. The concentration is 10 mg/mL, providing a total of 450 mg carboplatin in 45 mL. Carboplatin 450 mg/45 mL is supplied as a sterile solution for intravenous administration.

Active Ingredient

• Generic Name: Carboplatin
• Brand: Carboplatine Viatris
• Strength: 450 mg/45 mL
• Concentration: 10 mg/mL
• Dosage Form: Injection / infusion solution
• Route: Intravenous (IV)
• Therapeutic Class: Antineoplastic / platinum compound
• Pack: 45 mL vial

How Carboplatin Works

Carboplatin is a platinum-based chemotherapy medicine. It works primarily by forming bonds with DNA inside cancer cells, interfering with DNA replication and repair. This can prevent cancer cells from multiplying and ultimately lead to cancer-cell death.

Uses & Indications

Carboplatin is used as part of chemotherapy regimens for several cancers. Depending on the patient's diagnosis and treatment protocol, it may be used for conditions including:

• Ovarian cancer
• Lung cancer, including non-small-cell and small-cell lung cancer
• Head and neck cancers
• Other malignancies where carboplatin is included in an oncology treatment regimen

The exact indication and combination with other medicines depend on the cancer type, stage and individual treatment plan.

Strength & Pack Information

Each 45 mL vial contains 450 mg of carboplatin, at a concentration of 10 mg/mL. Carboplatin 450 mg/45 mL is a recognized presentation of carboplatin injection.

Dosage & Administration

Carboplatin dosing is individualized and is commonly calculated according to factors such as kidney function and the patient's treatment regimen. It is administered by intravenous infusion under the supervision of an oncologist or appropriately trained healthcare professional.

Do not self-administer or use carboplatin without specialist medical supervision.

Common Side Effects

Possible side effects may include:

• Nausea and vomiting
• Fatigue and weakness
• Decreased blood-cell counts
• Anemia
• Increased risk of infection
• Increased risk of bleeding
• Hair loss or thinning
• Changes in taste
• Peripheral neuropathy, including tingling or numbness
• Changes in kidney or liver laboratory values

Low blood counts are an important adverse effect of carboplatin treatment and require appropriate monitoring.

Important Warnings & Precautions

Carboplatin can cause bone-marrow suppression, which may reduce white blood cells, red blood cells and platelets. Blood counts should therefore be monitored during treatment.

The treating physician may also monitor kidney function, electrolytes and other laboratory parameters. Patients should inform their doctor about previous chemotherapy reactions, kidney disease, allergies and all medicines they are taking.

Carboplatin is a cytotoxic medicine and must be handled according to appropriate oncology and hazardous-drug procedures.

Storage

Storage requirements should follow the specific Viatris product information and packaging instructions. Carboplatin injection products are generally protected from light and stored under controlled room-temperature conditions according to their applicable product labeling.

Prescription & Administration

Carboplatine Viatris is a prescription oncology medicine. It should only be administered by qualified healthcare professionals in an appropriate medical/oncology setting.

Availability in Pakistan

Carboplatin 450 mg/45 mL injections are available through specialized oncology medicine suppliers in Pakistan, although brand availability can vary. Pakistani medicine listings also show other carboplatin 450 mg/45 mL brands, including Kemocarb and Carbotinol.

It may be sourced in major cities including:

Karachi, Lahore, Islamabad, Rawalpindi, Multan, Faisalabad, Peshawar, Gujranwala, Hyderabad, Bahawalpur, Sialkot, Sukkur, Larkana and other major cities of Pakistan.